Experimental Hematology
Volume 36, Issue 12 , Pages 1625-1633 , December 2008

4-Arylcoumarin analogues of combretastatins stimulate apoptosis of leukemic cells from chronic lymphocytic leukemia patients

  • Christian Billard

      Affiliations

    • UMRS 872 INSERM, Université Pierre et Marie Curie-Paris 6 and Université Paris Descartes, Equipe 18, Centre de Recherche des Cordeliers, Paris, France
    • Corresponding Author InformationOffprint requests to: Christian Billard, Ph.D., UMRS 872, Equipe 18, Centre de Recherche des Cordeliers, 15 rue de l'Ecole de Médecine, 75270 Paris Cedex 06, France
    • ,
  • Faouzia Menasria

      Affiliations

    • UMRS 872 INSERM, Université Pierre et Marie Curie-Paris 6 and Université Paris Descartes, Equipe 18, Centre de Recherche des Cordeliers, Paris, France
    • ,
  • Claire Quiney

      Affiliations

    • UMRS 872 INSERM, Université Pierre et Marie Curie-Paris 6 and Université Paris Descartes, Equipe 18, Centre de Recherche des Cordeliers, Paris, France
    • ,
  • Anne-Marie Faussat

      Affiliations

    • UMRS 872 INSERM, Université Pierre et Marie Curie-Paris 6 and Université Paris Descartes, Equipe 18, Centre de Recherche des Cordeliers, Paris, France
    • ,
  • Jean-Pierre Finet

      Affiliations

    • UMR 6264, Université d'Aix-Marseille I, II et III-CNRS, Equipe SREP, Faculté des Sciences de Saint Jérôme, Marseille, France
    • ,
  • Sébastien Combes

      Affiliations

    • UMR 6264, Université d'Aix-Marseille I, II et III-CNRS, Equipe SREP, Faculté des Sciences de Saint Jérôme, Marseille, France
    • ,
  • Jean-Pierre Kolb

      Affiliations

    • UMRS 872 INSERM, Université Pierre et Marie Curie-Paris 6 and Université Paris Descartes, Equipe 18, Centre de Recherche des Cordeliers, Paris, France

Received 18 March 2008 ,Revised 7 July 2008 ,Accepted 25 July 2008.

References 

  1. Pettit GR, Cragg GM, Singh SB. Antineoplastic agents, 122. Constituents of Combretum caffrum. J Nat Prod. 1987;50:386–391
  2. Lin CH, Singh SB, Chu PS, et al. Interactions of tubulin with potent natural and synthetic analogues of the antimitotic agent combretastatin: a structure-activity study. Mol Pharmacol. 1988;34:200–206
  3. Holwell SE, Cooper PA, Thompson MJ, et al. Anti-tumour and anti-vascular effects of the novel tubulin-binding agent combretastatin A-1 phosphate. Anticancer Res. 2002;22:3933–3940
  4. Tozer GM, Kanthou C, Parkins CS, Hill SA. The biology of the combretastatins as tumour vascular targeting agents. Int J Exp Pathol. 2002;83:21–38
  5. Pettit GR, Singh SB, Boyd MR, et al. Antineoplastic agents 291. Isolation ans synthesis of combretastatins A-4, A-5 and A-6. J Med Chem. 1995;38:1666–1672
  6. McGown AT, Fox BW. Differential cytotoxicity of combretastatins A1 and A4 in two daunorubicin-resistant P388 cell lines. Cancer Chemother Pharmacol. 1990;26:79–81
  7. Woods JA, Hadfield JA, Pettit GR, Fox BW, McGown AT. The interaction with tubulin of a series of stilbenes based on combretastatin A-4. Br J Cancer. 1995;71:705–711
  8. McGown AT, Fox BW. Structural and biochemical comparison of the anti-mitotic agents colchicine, combretastatin A4 and amphethinile. Anticancer Drug Res. 1989;3:249–254
  9. Bailly C, Bal C, Barbier P, et al. Synthesis and biological evaluation of combretastatins. J Med Chem. 2003;46:5437–5444
  10. Rappl C, Barbier P, Bourgarel-Rey V, et al. Interaction of 4-arylcoumarin analogues of combretastatins with microtubule network of HBL1 cells and binding to tubulin. Biochemistry. 2006;45:9210–9218
  11. Nabha SM, Mohammad RM, Dandashi MH, et al. Combretastatin-A4 prodrug induces mitotic catastrophe in chronic lymphocytic leukemia cell line independent of caspase activation and poly(ADP-ribose) polymerase cleavage. Clin Cancer Res. 2002;8:2735–2741
  12. Vitale I, Antoccia A, Cenciarelli C, et al. Combretastatin CA-4 and combretastatin derivative induce mitotic catastrophe dependent on spindle checkpoint and caspase-3 activation in non-small cell lung cancer cells. Apoptosis. 2007;12:155–156
  13. Fang L, He Q, Hu Y, Yang B. MZ3 induces apoptosis in human leukemia cells. Cancer Chemother Pharmacol. 2007;59:397–405
  14. Byrd JC, Stilgenbauer S, Flinn IW. Chronic lymphocytic leukemia. Hematology (Am Soc Hematol). 2004;4:163–183
  15. Kolb JP, Kern C, Quiney C, Roman V, Billard C. Re-establishment of a normal apoptotic process as a therapeutic approach in B-CLL. Curr Drug Targets Cardiovasc Haematol Disord. 2003;3:261–286
  16. Zhao H, Dugas N, Mathiot C, Dugas B, Sigaux F, Kolb JP. B-cell chronic lymphocytic leukemia cells express a functional inducible nitric oxide synthase displaying anti-apoptotic activity. Blood. 1998;92:1031–1043
  17. Kern C, Cornuel J, Billard C, et al. Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway. Blood. 2004;103:679–688
  18. Saltman D, Bansal NS, Ross FM, Turmer G, Guy K. Establishment of a karyotypically normal B-chronic lymphocytic leukemia cell line: evidence of leukemic origin by immunoglobin gene rearrangement. Leukemia Res. 1990;14:381–387
  19. Fourneron JD. Naït-Sy. Effect of eluent pH on HPLC/UV analysis of hyperforin. Phytochem Anal. 2006;17:71–77
  20. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood. 1994;84:1415–1420
  21. Billard C, Kern C, Tang R, Ajchenbaum-Cymbalista F, Kolb JP. Flavopiridol downregulates the expression of both the inducible NO synthase and p27kip1 in malignant cells from B-cell chronic lymphocytic leukemia. Leukemia. 2003;17:2345–2443
  22. Quiney C, Dauzonne D, Kern C, et al. Flavones and polyphenols inhibit the NO pathway during apoptosis of leukemia B-cells. Leukemia Res. 2004;28:851–861
  23. Roman V, Billard C, Kern C, et al. Analysis of resveratrol-induced apoptosis in human B-cell chronic leukemia. Br J Haematol. 2002;117:1–10
  24. Byrd JC, Shinn C, Waselenko JK, et al. Flavopiridol induces apoptosis in chronic lymphocytic leukemia via activation of caspase-3 and without evidence of bcl-2 modulation or dependence on functional p53. Blood. 1998;92:3804–3816
  25. Quiney C, Billard c Faussat AM, et al. Pro-apoptotic properties of hyperforin in leukemic cells from patients with chronic lymphocytic leukemia. Leukemia. 2006;20:491–497
  26. Vrhorac R, Delmer A, Tang R, Marie JP, Zittoun R, Ajchenbaum-Cymbalista F. Prognostic significance of the cell cycle inhibitor p27Kip1 in chronic lymphocytic leukemia. Blood. 1998;91:4694–4700
  27. Levesque MC, Misukonis MA, O'Loughlin CW, et al. IL-4 and interferon gamma regulate expression of inducible nitric oxide synthase in chronic lymphocytic leukemia cells. Leukemia. 2003;17:442–450
  28. Kolb JP. Mechanisms involved in the pro- and anti-apoptotic effects of NO in human leukemia. Leukemia. 2000;4:1685–1694
  29. Billard C, Izard JC, Roman V, et al. Comparative antiproliferative and apoptotic effects of resveratrol, ε-viniferin and vine-shots derived polyphenols (vineatrols) on chronic B lymphocytic leukemia cells and normal lymphocytes. Leuk Lymphoma. 2002;43:1991–2002
  30. Chiorazzi N. Cell proliferation and death: forgotten features of chronic lymphocytic leukemia B cells. Best Pract Res Clin Haematol. 2007;20:399–413
  31. Drexler HG, Quentmeier H, Dirks WG, MacLeod RA. DNA profiling and cytogenetic analysis of cell line WSU-CLL reveal cross-contamination with cell line REH (preB-ALL). Leukemia. 2002;16:1868–1870
  32. Byrd JC, Lin TS, Dalton JT, et al. Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytic leukemia. Blood. 2007;109:399–404
  33. Kitada S, Andersen J, Akar S, et al. Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses. Blood. 1998;91:3379–3389
  34. Pepper C, Thomas A, Hoy T, Fegan C, Bentley P. Flavopiridol circumvents Bcl-2 family mediated inhibition of apoptosis and drug resistance in B-cell chronic lymphocytic leukaemia. Br J Haematol. 2001;114:70–77
  35. Lin TS, Porcu P. Flavopiridol: where do we stand in chronic lymphocytic leukemia?. Leukemia. 2004;18:243–246

PII: S0301-472X(08)00354-8

doi: 10.1016/j.exphem.2008.07.008

Experimental Hematology
Volume 36, Issue 12 , Pages 1625-1633 , December 2008

Article Tools

* Image Usage & Resolution